FDA advisory panel calls for suicide warnings over new antidepressants

AUTOR(ES)

Moynihan, Ray

FONTE

BMJ Publishing Group Ltd.

Documentos Relacionados

• FDA panel urges "black box" warning for antidepressants
• FDA calls for warnings on anaemia drugs amid reports of incentives to doctors
• FDA again reviews antidepressants
• FDA moves to highlight warnings about HRT
• Antidepressants and suicide